Mark Turco, M.D.

President Medical Technologies

Dr. Mark A. Turco is a health care and business executive leader with private and public sector expertise in the clinical medicine, technology development and commercialization, and university-based innovation sectors. Dr. Turco most recently led R&D and medical/clinical activities at Sirtex Medical as the Chief Medical Officer and EVP R&D in the field of Interventional Oncology.

Previously, he acted as the University of Pennsylvania’s Chief Innovation and Corporate Outreach Officer. Dr. Turco led the development of Penn’s new medical device center and provided expertise for the University of Pennsylvania leaders, building relationships and partnerships with both internal and external clinicians, faculty and thought leaders, as part of the University’s efforts to expand innovation, technology, and translational opportunities regionally, nationally, and globally for the Universities Health system, Penn Medicine and across the academic campus. He was responsible for helping to successfully orchestrate external commercial partnerships to aid in the translation of Penn-based technologies and inventions across all sectors of clinical, biopharma, med device, digital health, and consumer-based products.

Dr. Turco spent 7 years working for large cap medical device companies, serving as Vice President and Chief Medical Officer of the vascular and neuro franchises for Medtronic, Inc. and Covidien, plc. In these roles, he informed strategy for complex business decisions regarding technologies and programs that encompassed patient considerations, clinical trial design, regulatory processes, physician training, evolving healthcare systems and valuebased models—both domestically and internationally. He also evaluated opportunities for growth and investment through medical, business, payers, providers, and regulators lenses and was integral to the evaluation of new business development prospects. Dr. Turco was instrumental in helping to build out Covidien’s vascular platform, which was subsequently a key component of Medtronic’s acquisition of Covidien.

Dr. Turco joined industry after a 20-year career in clinical medicine as an interventional cardiologist, serving as Director of the Cardiovascular Research Center at Washington Adventist Hospital. As a practicing cardiologist, Dr. Turco also played a role in the development from concept to commercialization of several medical devices currently being utilized in the field of cardiovascular medicine.